Presidio Partners 2007, L.P.'s Net Worth
$70.7 Million
Who is Presidio Partners 2007, L.P.?
Presidio Partners 2007, L.P. has an estimated net worth of $70.7 Million. This is based on reported shares across multiple companies, which include Auspex Pharmaceuticals, Inc., Neos Therapeutics, Inc., Menlo Therapeutics Inc., and ARDELYX, INC..
SEC CIK
Presidio Partners 2007, L.P.'s CIK is 0001405712
Past Insider Trading and Trends
2014 was Presidio Partners 2007, L.P.'s most active year for acquiring shares with 10 total transactions. Presidio Partners 2007, L.P.'s most active month to acquire stocks was the month of June. 2014 was Presidio Partners 2007, L.P.'s most active year for disposing of shares, totalling 35 transactions. Presidio Partners 2007, L.P.'s most active month to dispose stocks was the month of January. 2014 saw Presidio Partners 2007, L.P. paying a total of $2,162,984.74 for 3,948,432 shares, this is the most they've acquired in one year. In 2014 Presidio Partners 2007, L.P. cashed out on 1,193,945 shares for a total of $15,423,923.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Auspex Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.56% | -300.00K |
$29.79 | -$8,937,000.00 | 2.54M |
Apr 2
| |||
Form 4
| -6.58% | -200.00K |
—
|
—
| 2.84M |
Feb 24
| |||
Form 4
| -3.88% | -122.67K |
$63.08 | -$7,737,677.88 | 3.04M |
Feb 12 - Feb 13
| |||
Form 4/A
| -2.28% | -73.77K |
$61.59 | -$4,524,937.50 | 3.16M |
Feb 10 - Feb 11
| |||
Form 4
| +1.18% | 39K |
$26.51 | -$50.52 | 3.34M |
Jan 8
| |||
Form 4
| -1.29% | -84.15K |
$60.47 | -$5,138,150.00 | 6.43M |
Feb 9 - Feb 11
| |||
Form 4
| -2.79% | -93.18K |
$59.39 | -$5,533,673.92 | 3.25M |
Feb 4 - Feb 6
| |||
Form 4
| -13.15% | -500.00K |
$50.14 | -$9,777,300.00 | 3.3M |
Dec 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
| -0.50% | -19.00K |
$27.15 | -$515,812.62 | 3.8M |
Oct 29 - Oct 30
| |||
Form 4
| -0.38% | -14.50K |
$27.02 | -$391,799.20 | 3.82M |
Oct 27 - Oct 28
| |||
Form 4
| -0.43% | -16.50K |
$26.97 | -$444,950.16 | 3.84M |
Oct 23 - Oct 24
| |||
Form 4/A
| +0.94% | 35.86K |
$13.67 | -$5.39 | 3.85M |
Oct 6
| |||
Form 4
| +0.93% | 35.86K |
$13.67 | -$5.39 | 3.89M |
Oct 6
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4/A
| -0.59% | -22.70K |
$23.08 | -$523,980.38 | 3.84M |
Sep 2 - Sep 3
| |||
Form 4/A
| -0.22% | -8.70K |
$22.59 | -$196,552.14 | 3.87M |
Aug 29
| |||
Form 4/A
| -0.76% | -29.60K |
$22.03 | -$652,012.54 | 3.87M |
Aug 27 - Aug 28
| |||
Form 4/A
| -0.16% | -6.30K |
$21.35 | -$134,516.97 | 3.9M |
Aug 26
| |||
Form 4/A
| -0.14% | -5.40K |
$20.81 | -$112,358.34 | 3.91M |
Aug 25
| |||
Form 4/A
| -0.04% | -1.70K |
$20.56 | -$34,948.77 | 3.92M |
Aug 22
| |||
Form 4
| -0.67% | -25.60K |
$23.86 | -$610,806.27 | 3.82M |
Sep 4 - Sep 5
| |||
Form 4
| +1.22% | 47.03K |
$3.88 | $182,421.62 | 3.92M |
May 16
| |||
Form 4
| -0.59% | -22.70K |
$23.08 | -$523,980.38 | 3.8M |
Sep 2 - Sep 3
| |||
Form 4
| -0.23% | -8.70K |
$22.59 | -$196,552.14 | 3.82M |
Aug 29
| |||
Form 4
| -0.77% | -29.60K |
$22.03 | -$652,012.54 | 3.83M |
Aug 27 - Aug 28
| |||
Form 4
| -0.16% | -6.30K |
$21.35 | -$134,516.97 | 3.86M |
Aug 26
| |||
Form 4
| -0.14% | -5.40K |
$20.81 | -$112,358.34 | 3.86M |
Aug 25
| |||
Form 4
| -0.04% | -1.70K |
$20.56 | -$34,948.77 | 3.87M |
Aug 22
| |||
Form 4
|
∞
| 3.87M |
$12.00 | $1,266,732.00 | 3.87M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neos Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.26% | -20.37K |
$9.98 | -$203,344.29 | 1.6M |
Apr 18 - Apr 20
| |||
Form 4
| -3.45% | -57.97K |
$10.23 | -$593,288.50 | 1.62M |
Apr 13 - Apr 15
| |||
Form 4
| +102.56% | 1.28M |
—
|
—
| 2.52M |
Jul 27 - Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARDELYX, INC. (ARDX) Snapshot price: $5.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.56% | -300.00K |
—
|
—
| 2.54M |
Dec 15
| |||
Form 4
| -12.35% | -400.00K |
—
|
—
| 2.84M |
Apr 8
| |||
Form 4
| -4.99% | -170.00K |
$27.37 | -$4,652,900.00 | 3.24M |
Jan 30
| |||
Form 4
| -8.09% | -300.00K |
$24.25 | -$7,275,000.00 | 3.41M |
Jan 8
| |||
Form 4
| -9.73% | -400.00K |
—
|
—
| 3.71M |
Dec 30
| |||
Form 4
|
∞
| 4.11M |
$14.00 |
—
| 4.11M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||